{
    "links": "https://www.ycombinator.com/companies/cb-therapeutics",
    "name": "CB Therapeutics",
    "headline": "Fermentation-derived natural products to solve health problems",
    "batch": "S18",
    "description": "CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.",
    "activity_status": "Active",
    "website": "http://www.cbthera.com",
    "founded_date": null,
    "team_size": 18.0,
    "location": "San Diego, CA",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:cellular-agriculture; industry:biotech",
    "founders": [
        {
            "name": "Jacob Vogan, Founder",
            "description": "I'm focused on improving the human condition by driving scientific research and products which treat mental health disorders, increase our healthspan, and promote longevity. I've worked at UC Davis and UCSF as a researcher. I completed my PhD and postdoc at UC Berkeley. I co-founded CB Therapeutics with the goal of developing a synthetic biology solution to deliver affordable CBD, which has now expanded into novel cannabinoids and tryptamines, like psilocybin, to treat myriad health issues.",
            "linkedin": "https://www.linkedin.com/in/jacob-vogan-885212143"
        },
        {
            "name": "Sher Butt, Founder/CEO",
            "description": null,
            "linkedin": "https://www.linkedin.com/in/sherbutt/"
        }
    ],
    "status": true,
    "generated_description": "**CB Therapeutics: Pioneering Health Solutions through Synthetic Biology**\n\nCB Therapeutics is a synthetic biology company on a mission to harness the power of fermentation-derived natural products to tackle pressing health challenges. Founded as part of Y Combinator's Batch S18, this innovative startup is primarily focused on developing cannabinoid and tryptamine therapeutics. Located in San Diego, California, the company has a tight-knit team of 18 individuals dedicated to addressing a range of mental health issues including depression, PTSD, opioid addiction, alcoholism, and chronic pain.\n\n### What They Do\n\nCB Therapeutics aims to advance the field of synthetic biology by leveraging precision fermentation techniques. Their proprietary yeast platform enhances natural metabolic processes to produce a variety of compounds, including cannabinoids and psychedelics, with high purity and consistency. This efficient and scalable production method promises sustainable solutions for several industries\u2014including neuroscience, nutraceuticals, cosmetics, food, and beverage markets.\n\nHere are the primary focus areas:\n\n1. **Mental Health**: Developing treatments for disorders like depression and PTSD.\n2. **Physical Health & Wellness**: Creating therapeutic solutions for improved well-being.\n3. **Food Scarcity & Nutrition**: Innovating food tech through cellular agriculture.\n4. **Precision Fermentation**: Utilizing their cutting-edge bio-manufacturing capabilities.\n\n### Innovative Practices\n\nCB Therapeutics is ahead of the curve, building state-of-the-art facilities to expand their manufacturing capabilities. They are already supplying or negotiating partnerships across diverse sectors, underlining their commitment to meeting market demand with ethical, environmentally friendly products. \n\nThrough careful cultivation of their bio-manufacturing processes, they're not just contributing to modern health solutions; they're shaping the future of how we understand and produce health-related products. \n\nFor further inquiries or to learn more about their initiatives, check out their website [CB Therapeutics](http://www.cbthera.com).\n\n### Summary\n\nIn short, CB Therapeutics isn't just another biotech company\u2014it's on a quest to create a sustainable, healthier future through innovative science. By focusing on natural fermentation methods and addressing significant health issues, they hold potential not just for profits, but for positive global impact. Keep an eye on them; they could be at the forefront of the health revolution in the years to come.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/dda6bb3b9a1f4dc58eb7334a81fd81e5f27f4d3f.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAEHIR6H6F%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191044Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDt736ZW5EfzagAz1eKRSs%2FW4TfHu28RBSFaRNkZ9h47gIhANt6WXtwkgL07bQKDKYDGFxYKx7WOO9JX0BqaYrXnKNbKu4DCNz%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMMDA2MjAxODExMDcyIgx8TqkMwTM2PLcRmr4qwgPGGtQBXv7gs7%2BXGteI1gQk%2FjkbIHwQ5hCKXJKVmVAPw3MeVLhZyp8Nf5%2FYigbwE%2BrFR7aZWKjrs7HxAE0JWit5dlINZLjZK%2BS%2FwMaCqoj%2BFDN0gw9iiAPu4Xn5c3b%2BuZe%2F5%2Flfk0EuxZAXVsZtShxXZy%2FERPQ0v%2FRZxSz5qUoaXpL1zj6VWdWVzoI7%2FPlB3bgJ2PpiF7DN%2BJeDsJPx%2FoKTo5ehP9pOeGbMNxoeegVJsCJ3zvzO3o4fcZYIf6c5iIJwM1Ot3Gg7Z3v9oLZjSRU%2FaRLL5j4n3II7DaroOCEVfPlWzTyZM7SNFZZAFSKM8vLKj1VdTr9s3How41zluf%2FOIp7sGNhG%2FjuYJoG%2FmkLFIlYP4wbGrLO69AWnenZyfi1UhAiV6N%2BlAqGnqvpOJh4vq8uNh2eRnXR%2BMVXdq9oVYkm7XFgprL5PDC4ULLyBWqA6kca4z7F4H56nkT%2FsDtT8ek2VOIRIv1Zgcz%2BeeVG7F7AHS4bdbR6eZ3ChY1iQhfPBErh4OiFQM7IqiUKw%2B1CTpvL68xcVN5gjiaDH0Jotw%2BUcW9dMSg9py8xH8qgyiWG5w3dDj9xaoA2G3NMYq6JOGKMwwIrjvQY6pAHDH54nhADhmb7YSEGxHkL3pqs%2B6aYOExStWbzLKzRb3lb2DAgGG8uU9COt8%2FqUEOtOcszTKp7yuCJwMVkfI7PDZ74h9uiRkRxjtH7%2BLlE1xrfd%2FrIq%2B%2BZr9hSFqZ9MUQ4yNHesyx2FYDbsIfCW9ntlrpmZUHCcrzpQDfufsAFcpe%2FudVT3tUqiF8WCN1Vd%2Bx%2FQ9d3i1HvBcJWV9AYAwM0W22VM%2BA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=ae59b554f980194ecdab02da2c11e95d010ffb2d2a97b2e469452abc541a9a2d",
    "social_links": [
        "https://www.linkedin.com/company/6455436",
        "https://www.crunchbase.com/organization/cb-therapeutics"
    ],
    "logo_path": "data/logos\\CB_Therapeutics_logo.png"
}